You have 9 free searches left this month | for more free features.

Leukemia, Lymphoid

Showing 26 - 50 of 6,227

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023

Pediatric and Young Adult B-Cell Malignancies After Commercially

Not yet recruiting
  • Lymphoid Leukemia
  • Questionnaire for patients receiving therapy
  • Palo Alto, California
    Stanford University
May 9, 2023

Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

Not yet recruiting
  • Refractory B-cell Acute Lymphoblastic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Infective Complications and Outcome of ALL Treated With INO

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
    • (no location specified)
    Aug 29, 2023

    Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

    Not yet recruiting
    • Lymphoblastic Leukemia
    • Palo Alto, California
      Stanford University
    Apr 27, 2023

    Clinical Significance of Occult Central Nervous System

    Recruiting
    • Acute Lymphoblastic Leukemia
    • cerebrospinal fluids exams
    • Roma, RM, Italy
      Tor Vergata University
    Mar 17, 2023

    Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

    Active, not recruiting
    • Lymphoid Leukemia
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Dec 30, 2022

    ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

    Not yet recruiting
    • ALL, Childhood B-Cell
    • +2 more
    • Tafasitamab
    • (no location specified)
    Nov 25, 2022

    Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

    Recruiting
    • CLL/SLL
    • Jinan, Shandong, China
      Department of Hematology, Shandong Provincial Hospital Affiliate
    Jun 16, 2023

    Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

    Completed
    • Acute,Leukemia, Lymphoid
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Aug 2, 2022

    B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • QH103 Cell Injection
    • +2 more
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Sep 21, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Nov 22, 2023

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

    Not yet recruiting
    • B Precursor Acute Lymphoblastic Leukemia
    • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
    • (no location specified)
    Sep 25, 2023

    Acute Lymphoblastic Leukemia Trial in Saint Louis (Family-based Behavioral Weight Loss Treatment)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Family-based Behavioral Weight Loss Treatment
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 17, 2023

    Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Questionnaires
    • Fit Bit
    • Houston, Texas
      M D Anderson Cancer Center
    May 18, 2023

    Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Low-field magnetic resonance imaging
    • +3 more
    • Erlangen, Bavaria, Germany
      Department of Pediatrics and Adolescent Medicine
    Oct 23, 2023

    Optimize the Maintenance Phase of Childhood ALL

    Recruiting
    • Acute Lymphoblastic Leukemia
      • Trieste, Italy
        IRCCS materno infantile Burlo Garofolo
      Mar 31, 2023

      B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)

      Recruiting
      • B-cell Acute Lymphocytic Leukemia
      • CD19 CAR-T cells
      • Suzhou, China
        The First Affiliated Hospital of Soochow University
      Jan 11, 2023

      Pharmacogenomics of Asparaginase Induced Hepatotoxicity

      Suspended
      • Acute Lymphoblastic Leukemia
      • Biospecimen Collection
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Nov 18, 2022

      Acute Lymphoid Leukemia Trial in Seoul (Blincyto)

      Not yet recruiting
      • Acute Lymphoid Leukemia
      • Seoul, Gangnam-gu, Korea, Republic of
      • +4 more
      Apr 12, 2023

      Understanding Chronic Lymphocytic Leukemia

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Aug 1, 2022

        Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

        Recruiting
        • Burkitt Lymphoma
        • +2 more
        • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
        • Zhuhai, Guangdong, China
          The Fifth Affiliated Hospital of Sun Yat-sen University
        Sep 25, 2023

        T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

        Recruiting
        • T Lymphoblastic Leukemia/Lymphoma
        • Hangzhou, Zhejiang, China
          The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
        Aug 7, 2023